Elanco Animal Health advertising spend, FY2025
Elanco Animal Health (ELAN) reported $314M of marketing and advertising expense for the fiscal year ended Dec 31, 2025. It does not tag advertising separately, so this broader figure stands in for it. That is 6.7% of revenue of $4.7B. Up 33.1% from FY2024.
Key facts
- Ad spend is 1.3x its FY2021 level ($248M), faster than revenue (1.0x).
- FY2025 is the highest year on file, going back to FY2021.
- Largest increase +33.1% in FY2025; largest cut -19.0% in FY2022.
- Ad spend has risen 3 years in a row.
- Elanco Animal Health's marketing and advertising expense is higher than the figure of 64% of the 458 US-listed companies tracked. Its ad-to-revenue ratio is 1.5x the median of 4.5%.
Ad spend by fiscal year
Ad spend as % of revenue
Ad spend in context, FY2025
Advertising was 22.0% of selling, general and administrative expense. Research and development spending was 1.2x advertising.
| Advertising | $314M | MarketingAndAdvertisingExpense |
|---|---|---|
| Selling, general and administrative | $1.4B | ad spend = 22.0% |
| Research and development | $368M | R&D = 1.2x ad spend |
| Net loss | -$232M |
Same fiscal year and filing as the ad spend. Selling and marketing and SG&A usually include advertising.
History
Download CSV| Fiscal year | Period end | Ad spend | YoY | Revenue | Ad / revenue | Tag | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | $314M | +33.1% | $4.7B | 6.7% | MarketingAndAdvertisingExpense | 10-K Feb 24, 2026 |
| FY2024 | Dec 31, 2024 | $236M | +14.0% | $4.4B | 5.3% | MarketingAndAdvertisingExpense | 10-K Feb 24, 2026 |
| FY2023 | Dec 31, 2023 | $207M | +3.0% | $4.4B | 4.7% | MarketingAndAdvertisingExpense | 10-K Feb 24, 2026 |
| FY2022 | Dec 31, 2022 | $201M | -19.0% | $4.4B | 4.6% | MarketingAndAdvertisingExpense | 10-K Feb 25, 2025 |
| FY2021 | Dec 31, 2021 | $248M | n/a | $4.8B | 5.2% | MarketingAndAdvertisingExpense | 10-K Feb 26, 2024 |
Ad spend, revenue and the ratio come from the linked filing. YoY compares each year with the fiscal year directly before it, under the same tag. A gap, a change of tag or a change of fiscal year end leaves it blank.
What the figure is
Marketing and advertising combined, as reported under the XBRL tag MarketingAndAdvertisingExpense. It is broader than advertising alone.
Compared with similar spenders
The 6 companies closest to Elanco Animal Health in latest-year ad spend.
| Rank | Company | Ad spend | Ad / revenue | YoY | Fiscal year |
|---|---|---|---|---|---|
| 162 | People Inc. | $328M | 13.7% | +3.3% | FY2025 |
| 163 | Celsius | $319M | 12.7% | +43.9% | FY2025 |
| 164 | Hasbro | $317M | 5.9% | -0.8% | FY2025 |
| 165 | Elanco Animal Health | $314M | 6.7% | +33.1% | FY2025 |
| 166 | Teva Pharmaceutical | $309M | 1.8% | +19.3% | FY2025 |
| 167 | Abercrombie & Fitch | $308M | 5.9% | +13.9% | FY2026 |
| 168 | Zoetis | $308M | 3.3% | +2.0% | FY2025 |
Questions
How much does Elanco Animal Health spend on advertising?
Elanco Animal Health does not report advertising separately. Its marketing and advertising expense was $314M in fiscal 2025, the year ended Dec 31, 2025, according to its 10-K filed Feb 24, 2026. That figure is broader than advertising.
What percentage of revenue does Elanco Animal Health spend on advertising?
6.7% of revenue in fiscal 2025 ($314M of marketing and advertising expense against $4.7B). The median across the 458 companies tracked is 4.5%.
Is Elanco Animal Health spending more on advertising?
Yes. Ad spend rose 33.1% in fiscal 2025 from fiscal 2024. It has risen 3 years in a row.
How does Elanco Animal Health rank by advertising spend?
#165 of 458 US-listed companies with $50M or more in ad spend, ranked on each company's latest fiscal year.
Does Elanco Animal Health spend more on advertising than on R&D?
No. In fiscal 2025 it spent $368M on research and development and $314M on advertising.
What does Elanco Animal Health's advertising figure include?
Marketing and advertising combined, as reported under the XBRL tag MarketingAndAdvertisingExpense. It is broader than advertising alone.
Company and source
- Filing
- 10-K for FY2025, filed Feb 24, 2026
- Accession number
0001739104-26-000012- Company
- Elanco Animal Health Inc, CIK 1739104, SIC 2834 (Pharmaceutical Preparations)
- Headquarters
- Indianapolis, IN
- Fiscal year ends
- December 31
- Listed on
- NYSE
- SEC filer status
- Large accelerated filer
- Data
- SEC EDGAR XBRL company facts, retrieved Nov 18, 2026. Methodology.
- Cite
- Elanco Animal Health advertising spend, FY2021-FY2025. Aleksei Trudov, io.trudov.com, from SEC EDGAR XBRL company facts (latest: 10-K filed Feb 24, 2026), retrieved Nov 18, 2026. https://io.trudov.com/company/elanco-animal-health/advertising-spend/
- Download
- CSV, all years · CSV, all 458 companies